As of 1/31/2018 13:00, our instrument has been replaced and there should be no delay in testing.
Serum and Urine Osmolality requests will be delayed for up to 24 hours until further notice due to instrumentation malfunction. Please contact the Chemistry Department with any questions or concerns. We apologize for any inconvenience that this may cause.
As of 1/12/2018, the analyzer has been repaired and all specimens have been resulted.
The Dynex DS2 analyzer in the Chemistry department at Spectrum Health Regional Laboratory is currently down until Tuesday, January 2, 2018. Results for TB Screen (QuantiFERON Gold) on tests collected since December 21, 2017 will be delayed. Specimens are stable for 27 days, so the patient will not need to be recollected. We apologize for any inconvenience.
If you have further questions, please contact the Laboratory Call Center or use the “contact us” link above. This post will be updated when the analyzer is serviced.
As of Thursday, November 7th, pediatric reference intervals for alkaline phosphatase were changed at Spectrum Health Regional Laboratory to reflect the reference intervals stated by the assay’s manufacturer, Roche Diagnostics. Their values are consistent with recommendations from CALIPER studies on pediatric reference intervals.
Effective November 5, 2017, the 1,25-Dihydroxyvitamin D test will have its name changed to Calcitriol (1,25-Dihydroxyvitamin D) in the Epic, Cerner and eSHare systems.
On May 1, 2017, Spectrum Health Regional Laboratory adjusted the reference range for C-Reactive Protein (CRP) from ≤10 mg/L to ≤5.0 mg/L.
On March 21, 2017, Spectrum Health Regional Laboratory (SHRL) will be switching instrument/vendors that perform the Beta CTX (BCTX assay); we will be switching from the ROCHE COBAS® platform to the ISYS-IDS platform. Both methods compare very well, however reference ranges will change due to the different methods.
As of February 7, 2017 the method/instrument used for the Growth Hormone assay performed at the Spectrum Health Regional Laboratory will be switched from ROCHE COBAS to the IDS- iSYS. A method comparison between the two methods showed excellent clinical and numerical comparability. The assay also performed excellently in terms of precision and linearity.
Spectrum Health Reed City Laboratory will be switching instrument vendors, from Beckman Coulter to Roche, Tuesday November 29th, 2016. The change will be seamless for all tests except Troponin and B-type Natriuretic Peptide, as both of those tests are specific by vendor they will change to reflect those of the new vendor.
Troponin I will be switched to Troponin T.
BNP will be switched to NT-ProBNP.
New cardiac marker numerical results and reference ranges will not be interchangeable with the old. The new markers are consistent with what is in place at Spectrum Health Grand Rapids, Gerber and Zeeland Hospital Laboratories. Spectrum Health Big Rapids, United and Kelsey Hospital Laboratories will be following suit over the next 12 months.
The Spectrum Health Regional Laboratory is pleased to announce that the QuantiFERON® -TB Gold test for the detection of Mycobacterium tuberculosis has been added to our in-house test menu.
On September 1, 2015, Spectrum Health Regional Laboratory, in conjunction with Infectious Disease, Infection Prevention and Pharmacy, adjusted reflex criteria for urine culture based on urinalysis finding (Urinalysis, Do Culture if Indicated – Test #115, Epic #LAB348, UA CX DO IF). The adjustment involved an increase in the number of WBCs per HPF considered positive (from ≥3 to ≥10).